The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
ACE2, Much More Than Just a Receptor for SARS-COV-2
Open accessAbstract
The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) has been identified as the receptor for the SARS-CoV-2 viral entry. As such, it is now receiving renewed attention as a potential target for anti-viral therapeutics. We review the physiological functions of ACE2 in the cardiovascular system and the lungs, and how the activation of ACE2/MAS/G protein coupled receptor contributes in reducing acute injury and inhibiting fibrogenesis of the lungs and protecting the cardiovascular system. In this perspective, we predominantly focus on the impact of SARS-CoV-2 infection on ACE2 and dysregulation of the protective effect of ACE2/MAS/G protein pathway vs. the deleterious effect of Renin/Angiotensin/Aldosterone. We discuss the potential effect of invasion of SARS-CoV-2 on the function of ACE2 and the loss of the protective effect of the ACE2/MAS pathway in alveolar epithelial cells and how this may amplify systemic deleterious effect of renin-angiotensin aldosterone system (RAS) in the host. Furthermore, we speculate the potential of exploiting the modulation of ACE2/MAS pathway as a natural protection of lung injury by modulation of ACE2/MAS axis or by developing targeted drugs to inhibit proteases required for viral entry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.02.034 · Cited by 6,069
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.045 · Cited by 2,892
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Mulangu, S., Dodd, L. E., Davey, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., Ibanda, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910993 · Cited by 1,605
Zhu, L., She, Z.-G., Cheng, X., Qin, J.-J., Zhang, X.-J., Cai, J., Lei, F., Wang, H., Xie, J., Wang, W., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.021 · Cited by 1,602
Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435
Real estimates of mortality following COVID-19 infection
Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., & Favre, G. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30195-x · Cited by 1,253
Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,230
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,073
Moore, J. X., Chaudhary, N., & Akinyemiju, T. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160287 · Cited by 935
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
Heurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & Pöhlmann, S. (2014) · Journal of Virology · doi:10.1128/jvi.02202-13 · Cited by 881
Pre-fusion structure of a human coronavirus spike protein
Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2016) · Nature · doi:10.1038/nature17200 · Cited by 765
Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Magagnoli, J., Narendran, S., Pereira, F., Cummings, T. H., Hardin, J. W., Sutton, S. S., & Ambati, J. (2020) · Med · doi:10.1016/j.medj.2020.06.001 · Cited by 656
Tikellis, C., & Thomas, M. C. (2012) · International Journal of Peptides · doi:10.1155/2012/256294 · Cited by 624
A previously undescribed coronavirus associated with respiratory disease in humans
Fouchier, R. A. M., Hartwig, N. G., Bestebroer, T. M., Niemeyer, B., de Jong, J. C., Simon, J. H., & Osterhaus, A. D. M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400762101 · Cited by 598
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China
Porcheddu, R., Serra, C., Kelvin, D., Kelvin, N., & Rubino, S. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12600 · Cited by 434
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney
Ruiz-Ortega, M., Ruperez, M., Lorenzo, O., Esteban, V., Blanco, J., Mezzano, S., & Egido, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.4.x · Cited by 425
NADPH oxidases and angiotensin II receptor signaling
Garrido, A. M., & Griendling, K. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.003 · Cited by 386
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Diaz, J. H. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa041 · Cited by 350
Krijnse-Locker, J., Ericsson, M., Rottier, P., & Griffiths, G. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.55 · Cited by 340
Glass, W. G., Subbarao, K., Murphy, B., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 340
Chloroquine Transport via the Malaria Parasite’s Chloroquine Resistance Transporter
Martin, R. E., Marchetti, R. V., Cowan, A. I., Howitt, S. M., Bröer, S., & Kirk, K. (2009) · Science · doi:10.1126/science.1175667 · Cited by 331
Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
Roca-Ho, H., Riera, M., Palau, V., Pascual, J., & Soler, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030563 · Cited by 301
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
Angiotensin II and the Endothelium: Diverse Signals and Effects
Watanabe, T., Barker, T. A., & Berk, B. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000153321.13792.b9 · Cited by 227
Architecture and function of metallopeptidase catalytic domains
Cerdà‐Costa, N., & Xavier Gomis‐Rüth, F. (2014) · Protein Science · doi:10.1002/pro.2400 · Cited by 209
Initial viral load and the outcomes of SARS
Chu, C.-M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040398 · Cited by 196
The renin angiotensin system and the metabolic syndrome
de Kloet, A. D., Krause, E. G., & Woods, S. C. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.018 · Cited by 194
Angiotensin II induces apoptosis in human and rat alveolar epithelial cells
Wang, R., Zagariya, A., Ibarra-Sunga, O., Gidea, C., Ang, E., Deshmukh, S., Chaudhary, G., Baraboutis, J., Filippatos, G., & Uhal, B. D. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l885 · Cited by 186
Self-citationLi, X., Molina-Molina, M., Abdul-Hafez, A., Uhal, V., Xaubet, A., & Uhal, B. D. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2008 · Cited by 182
Self-citationInduction of Interleukin-6 Expression by Angiotensin II in Rat Vascular Smooth Muscle Cells
Funakoshi, Y., Ichiki, T., Ito, K., & Takeshita, A. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.118 · Cited by 182
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175
Turner, A. J., Tipnis, S. R., Guy, J. L., Rice, G. I., & Hooper, N. M. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-021 · Cited by 169
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., & Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000248135.97380.76 · Cited by 169
Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications
Singh, K. D., & Karnik, S. S. (2017) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000111 · Cited by 142
ACE2 Activation Promotes Antithrombotic Activity
Fraga-Silva, R. A., Sorg, B. S., Wankhede, M., deDeugd, C. M., Jun, J. Y., Baker, M. B., Li, Y., Castellano, R. K., Katovich, M. J., Raizada, M. K., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00160 · Cited by 133
ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Jiang, T., Gao, L., Lu, J., & Zhang, Y. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020007 · Cited by 126
Nabah, Y. N. A., Mateo, T., Estellés, R., Mata, M., Zagorski, J., Sarau, H., Cortijo, J., Morcillo, E. J., Jose, P. J., & Sanz, M.-J. (2004) · Circulation · doi:10.1161/01.cir.0000148824.93600.f3 · Cited by 124
Plasma angiotensins and blood pressure during converting enzyme inhibition.
Mento, P. F., & Wílkes, B. M. (1987) · Hypertension · doi:10.1161/01.hyp.9.6_pt_2.iii42 · Cited by 116
Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1–7/Mas axis
Uhal, B. D., Li, X., Xue, A., Gao, X., & Abdul‐Hafez, A. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00222.2010 · Cited by 114
Self-citationWakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., Makino, Y., Kato, N., Koni, I., & Miyamori, I. (2007) · Endocrinology · doi:10.1210/en.2006-1287 · Cited by 113
Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
Rey-Parra, G., Vadivel, A., Coltan, L., Hall, A., Eaton, F., Schuster, M., Loibner, H., Penninger, J. M., Kassiri, Z., Oudit, G. Y., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0859-2 · Cited by 113
Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy-0
Schindler, C., Bramlage, P., Kirch, W., & Ferrario, C. M. (2011) · PubMed Central · doi:10.6084/m9.figshare.62679 · Cited by 111
Xue, B., Beltz, T. G., Yu, Y., Guo, F., Gómez-Sánchez, C. E., Hay, M., & Johnson, A. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00847.2010 · Cited by 106
Angiotensin II–Mediated Microvascular Thrombosis
Senchenkova, E. Y., Russell, J., Almeida-Paula, L. D., Harding, J. W., & Granger, D. N. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158220 · Cited by 103
Malhotra, A., Kang, B. P. S., Cheung, S., Opawumi, D., & Meggs, L. G. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1918 · Cited by 96
Angiotensin-(1-7) and the Rat Aorta: Modulation by the Endothelium
le Tran, Y., & Forster, C. M. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199711000-00019 · Cited by 89
HIF-1α regulates IL-1β and IL-17 in sarcoidosis
Talreja, J., Talwar, H. S., Bauerfeld, C. P., Grossman, L. I., Zhang, K., Tranchida, P., & Samavati, L. (2019) · eLife · doi:10.7554/elife.44519 · Cited by 71
Self-citationLu, H., Ai, J., Shen, Y., Li, Y., Li, T., Zhou, X., Zhang, H., Zhang, Q., Ling, Y., Wang, S., et al. (2020) · medRxiv · doi:10.1101/2020.02.19.20025031 · Cited by 61
Ramachandran, V., Ismail, P., Stanslas, J., Shamsudin, N., Moin, S., & Jas, R. M. (2008) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320308097499 · Cited by 60
Potentiation of angiotensin II action by corticosteroids in vascular tissue
Ullian, M. E. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00053-3 · Cited by 58
Effects of Angiotensin II Infusion and Inhibition of Nitric Oxide Synthase on the Rat Aorta
Kato, H., Hou, J., Chobanian, A. V., & Brecher, P. I. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.153 · Cited by 44
Gustafsson, F. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00174-1 · Cited by 43
Hyperoxia downregulates angiotensin-converting enzyme-2 in human fetal lung fibroblasts
Oarhe, C. I., Dang, V., Dang, M., Nguyen, H. T. T., Gopallawa, I., Gewolb, I. H., & Uhal, B. D. (2015) · Pediatric Research · doi:10.1038/pr.2015.27 · Cited by 40
Self-citationAlternative pathways for angiotensin II generation in the cardiovascular system.
Becari, C., Oliveira, E., & Salgado, M. C. O. (2011) · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · doi:10.1590/s0100-879x2011007500093 · Cited by 40
Gopallawa, I., & Uhal, B. D. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00187.2015 · Cited by 39
Self-citationCinatl, J. J., Michaelis, M., Morgenstern, B., & Doerr, H. W. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.2.323 · Cited by 34
Nguyen, H. T. T., & Uhal, B. D. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00449.2015 · Cited by 27
Self-citationThe Discovery of the ACE2 Gene
Marian, A. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.301271 · Cited by 22
Cited by
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Scialo, F., Daniele, A., Amato, F., Pastore, L., Matera, M. G., Cazzola, M., Castaldo, G., & Bianco, A. (2020) · Lung · doi:10.1007/s00408-020-00408-4 · Cited by 481
Severe covid-19 pneumonia: pathogenesis and clinical management
Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M., & Hatipoğlu, U. (2021) · BMJ · doi:10.1136/bmj.n436 · Cited by 437
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Metadata
- Authors
- Samavati, L., & Uhal, B. D.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-05
- Volume
- 10
- Pages
- 317-317
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W3033314946
- Cited by
- 364
- References
- 81
- FWCI
- 41.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.